World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01477996
Date of registration: 08/08/2011
Primary sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Public title: Pain After Intravitreal Therapy
Scientific title:
Date of first enrolment: August 2011
Target sample size: 200
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01477996
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
Austria
Contacts
Name:   Christiane I Falkner-Radler, MD
Address: 
Telephone: 0043711654607
Email: christiane.falkner-radler@wienkav.at
Affiliation: 
Name:   Christiane I Falkner-Radler, MD
Address: 
Telephone: 0043711654607
Email: christiane.falkner-radler@wienkav.at
Affiliation: 
Name:   Christiane I Falkner-Radler, MD
Address: 
Telephone:
Email:
Affiliation:  The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Name:   Susanne Binder, MD
Address: 
Telephone:
Email:
Affiliation:  The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Key inclusion & exclusion criteria

Inclusion Criteria:

- vitrearetinal disease including age-related macular degeneration,

- clinical significant macular edema due to diabetic retinopathy or other vascular
disorders

- treatment with intravitreal therapy

Exclusion Criteria:

- missing informed consent

- age under 50 years



Age minimum: 51 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Pain
Intervention(s)
Procedure: 27-gauge
Procedure: 30-gauge
Primary Outcome(s)
Visual Analoge Scale [Time Frame: 1 day, after the intravitreal therapy (IVT)]
Secondary Outcome(s)
Baker scale [Time Frame: 1 day, after the intravitreal therapy (IVT)]
patients demographic data [Time Frame: 1 day, record of patients data before or after intravitreal therapy (IVT)]
Secondary ID(s)
FR-7-CI-2011
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history